Stopping cannabis use benefits outcome in psychosis: findings from 10‐year follow‐up study in the PAFIP‐cohort
E. Setién-Suero, Karl Neergaard, V. Ortiz-García de la Foz, P. Suárez-Pinilla, O. Martínez‐García, B. Crespo-Facorro, R. Ayesa‐Arriola
Acta Psychiatrica Scandinavica August 5, 2019 DOI: 10.1111/acps.13081 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Population | Patients with first episode of psychosis (FEP) |
| Duration | Up to 10 years |
| Topics | Cannabis |
| Key findings | The study indicates that long-term cannabis use in patients with first-episode psychosis is associated with poorer clinical and functional outcomes over up to 10 years. The effect on neurocognition is not specified in the abstract. |
Abstract
To examine the long‐term (up to 10 years) patterns related to cannabis use in a sample of patients with first episode of psychosis (FEP) and the effect that consumption might have on clinical, functioning, and neurocognition at long‐term.